Author Archives: Jill Wechsler

New FDA Campaign Targets Detailing, Trade Shows

In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory | Tagged , , , , , , | Leave a comment

Government to Launch Academic Detailing Program

Some of the $1.1 billion in funding for Comparative Effectiveness Research (CER) provided by last year’s economic stimulus legislation will be used to support a major doctor education campaign on drugs and medical products and procedures. The Agency for Healthcare Research and Quality (AHRQ) plans to contract this fall with a marketing or advertising company [...]
Posted in Medical Education, News, Sales, Strategy | Tagged , , , | 2 Comments

Pharma Cheers Health Reform Legislation

Image by SEIU International via Flickr After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly. Of most importance to pharmaceutical companies, the legislation promises to significantly expand the [...]
Posted in News | Tagged , , , , , , , | 3 Comments

Tauzin’s Farewell to PhRMA

Image via Wikipedia In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our backs—to [...]
Posted in People, Regulatory | Tagged , , , , , , , | Leave a comment

Obama Reveals Healthcare Reform Plan

Image via Wikipedia The health reform proposal unveiled by the White House on Feb. 22, 2010 retains a number of provisions that directly affect drug coverage and industry revenues. The plan highlights that it will close the Medicare drug benefit “doughnut hole” by 2020 to make drugs more affordable to the elderly. Seniors will get some [...]
Posted in News, Regulatory | Tagged , , , , , | 3 Comments